Inzen Therapeutics

Inzen Therapeutics is an early-stage biotechnology company committed to targeting cell turnover as a key driver of disease. Inzen is developing a broad pipeline of novel drugs based on its proprietary insights into Thanokine™ biology. These represent new approaches to treating cancer, reversing or halting fibrosis and inflammation, and promoting tissue regeneration.